Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Other Working Capital Changes (2020 - 2026)

Cytek Biosciences filings provide 6 years of Other Working Capital Changes readings, the most recent being $4.3 million for Q4 2025.

  • On a quarterly basis, Other Working Capital Changes fell 15.91% to $4.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.6 million, a 28.2% increase, with the full-year FY2025 number at $3.6 million, up 28.2% from a year prior.
  • Other Working Capital Changes hit $4.3 million in Q4 2025 for Cytek Biosciences, up from -$1.1 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $20.8 million in Q4 2022 to a low of -$7.9 million in Q3 2023.
  • Median Other Working Capital Changes over the past 5 years was $1.2 million (2021), compared with a mean of $1.9 million.
  • Biggest five-year swings in Other Working Capital Changes: crashed 656.63% in 2022 and later surged 2502.02% in 2023.
  • Cytek Biosciences' Other Working Capital Changes stood at $1.2 million in 2021, then skyrocketed by 1561.6% to $20.8 million in 2022, then crashed by 58.24% to $8.7 million in 2023, then crashed by 41.1% to $5.1 million in 2024, then decreased by 15.91% to $4.3 million in 2025.
  • The last three reported values for Other Working Capital Changes were $4.3 million (Q4 2025), -$1.1 million (Q3 2025), and $1.5 million (Q2 2025) per Business Quant data.